Answers are grounded in this paper and cite their sources.
Patent foramen ovale (PFO) is a common interatrial communication that is present in approximately 25% of the general population.Although it is usually asymptomatic, PFO can function as a conduit for paradoxical embolism, thereby contributing to cryptogenic stroke and other embolic events.Over the past decade, accumulating evidence has clarified the benefit of transcatheter PFO closure in carefully selected patients, particularly those with high-risk anatomical features such as a large right-to-left shunt or an atrial septal aneurysm.Clinical tools, including the Risk of Paradoxical Embolism score and the PFO-Associated Stroke Causal Likelihood classification, assist clinicians in estimating causality and refining patient selection.This review summarizes current indications for PFO closure, the role of high-risk anatomical features, key randomized trial evidence, and guideline-directed algorithmic approaches.Emphasis is placed on precise risk stratification, appropriate patient selection, and the integration of clinical and anatomical factors to optimize outcomes in the management of PFO-associated stroke.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: